IP Library Assignment 050093/0189
Patent Assignment
Reel/Frame 050093/0189

Assignment of Assignor's Interest

Recorded: 2019-08-19 Pages: 7
Assignors
JONES, PHILIP
Executed: 2019-08-15
CZAKO, BARBARA
Executed: 2019-08-15
CARROLL, CHRISTOPHER L.
Executed: 2019-08-15
MANDAL, PIJUS
Executed: 2019-08-15
CROSS, JASON
Executed: 2019-08-15
Assignee
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
201 WEST 7TH ST., AUSTIN, TEXAS, 78701
Covered Property (1)
PTPN11 Inhibitors
Application: 16/536,923 →
Publication: US 2020/0048249
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 21, 2020
From: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
To: NAVIRE PHARMA, INC.
Reel/Frame 054130/0519 →
Security Interest Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Security Interest Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Release of Security Interest in Patent Collateral Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0095 →
Assignment of Assignor's Interest Sep 4, 2025
From: NAVIRE PHARMA, INC.
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 072160/0110 →